Cargando…

Differential Diagnosis of Hyperferritinemia in Critically Ill Patients

Background: Elevated serum ferritin is a common condition in critically ill patients. It is well known that hyperferritinemia constitutes a good biomarker for hemophagocytic lymphohistiocytosis (HLH) in critically ill patients. However, further differential diagnoses of hyperferritinemia in adult cr...

Descripción completa

Detalles Bibliográficos
Autores principales: Schuster, Friederike S., Nyvlt, Peter, Heeren, Patrick, Spies, Claudia, Adam, Moritz F., Schenk, Thomas, Brunkhorst, Frank M., Janka, Gritta, La Rosée, Paul, Lachmann, Cornelia, Lachmann, Gunnar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821140/
https://www.ncbi.nlm.nih.gov/pubmed/36614993
http://dx.doi.org/10.3390/jcm12010192
_version_ 1784865626428276736
author Schuster, Friederike S.
Nyvlt, Peter
Heeren, Patrick
Spies, Claudia
Adam, Moritz F.
Schenk, Thomas
Brunkhorst, Frank M.
Janka, Gritta
La Rosée, Paul
Lachmann, Cornelia
Lachmann, Gunnar
author_facet Schuster, Friederike S.
Nyvlt, Peter
Heeren, Patrick
Spies, Claudia
Adam, Moritz F.
Schenk, Thomas
Brunkhorst, Frank M.
Janka, Gritta
La Rosée, Paul
Lachmann, Cornelia
Lachmann, Gunnar
author_sort Schuster, Friederike S.
collection PubMed
description Background: Elevated serum ferritin is a common condition in critically ill patients. It is well known that hyperferritinemia constitutes a good biomarker for hemophagocytic lymphohistiocytosis (HLH) in critically ill patients. However, further differential diagnoses of hyperferritinemia in adult critically ill patients remain poorly investigated. We sought to systematically investigate hyperferritinemia in adult critically ill patients without HLH. Methods: In this secondary analysis of a retrospective observational study, patients ≥18 years admitted to at least one adult intensive care unit at Charité–Universitätsmedizin Berlin between January 2006 and August 2018, and with hyperferritinemia of ≥500 μg/L were included. Patients with HLH were excluded. All patients were categorized into non-sepsis, sepsis, and septic shock. They were also classified into 17 disease groups, based on their ICD-10 codes, and pre-existing immunosuppression was determined. Uni- and multivariable linear regression analyses were performed in all patients. Results: A total of 2583 patients were analyzed. Multivariable linear regression analysis revealed positive associations of maximum SOFA score, sepsis or septic shock, liver disease (except hepatitis), and hematological malignancy with maximum ferritin. T/NK cell lymphoma, acute myeloblastic leukemia, Kaposi’s sarcoma, acute or subacute liver failure, and hepatic veno-occlusive disease were positively associated with maximum ferritin in post-hoc multivariable linear regression analysis. Conclusions: Sepsis or septic shock, liver disease (except hepatitis) and hematological malignancy are important differential diagnoses in hyperferritinemic adult critically ill patients without HLH. Together with HLH, they complete the quartet of important differential diagnoses of hyperferritinemia in adult critically ill patients. As these conditions are also related to HLH, it is important to apply HLH-2004 criteria for exclusion of HLH in hyperferritinemic patients. Hyperferritinemic critically ill patients without HLH require quick investigation of differential diagnoses.
format Online
Article
Text
id pubmed-9821140
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-98211402023-01-07 Differential Diagnosis of Hyperferritinemia in Critically Ill Patients Schuster, Friederike S. Nyvlt, Peter Heeren, Patrick Spies, Claudia Adam, Moritz F. Schenk, Thomas Brunkhorst, Frank M. Janka, Gritta La Rosée, Paul Lachmann, Cornelia Lachmann, Gunnar J Clin Med Article Background: Elevated serum ferritin is a common condition in critically ill patients. It is well known that hyperferritinemia constitutes a good biomarker for hemophagocytic lymphohistiocytosis (HLH) in critically ill patients. However, further differential diagnoses of hyperferritinemia in adult critically ill patients remain poorly investigated. We sought to systematically investigate hyperferritinemia in adult critically ill patients without HLH. Methods: In this secondary analysis of a retrospective observational study, patients ≥18 years admitted to at least one adult intensive care unit at Charité–Universitätsmedizin Berlin between January 2006 and August 2018, and with hyperferritinemia of ≥500 μg/L were included. Patients with HLH were excluded. All patients were categorized into non-sepsis, sepsis, and septic shock. They were also classified into 17 disease groups, based on their ICD-10 codes, and pre-existing immunosuppression was determined. Uni- and multivariable linear regression analyses were performed in all patients. Results: A total of 2583 patients were analyzed. Multivariable linear regression analysis revealed positive associations of maximum SOFA score, sepsis or septic shock, liver disease (except hepatitis), and hematological malignancy with maximum ferritin. T/NK cell lymphoma, acute myeloblastic leukemia, Kaposi’s sarcoma, acute or subacute liver failure, and hepatic veno-occlusive disease were positively associated with maximum ferritin in post-hoc multivariable linear regression analysis. Conclusions: Sepsis or septic shock, liver disease (except hepatitis) and hematological malignancy are important differential diagnoses in hyperferritinemic adult critically ill patients without HLH. Together with HLH, they complete the quartet of important differential diagnoses of hyperferritinemia in adult critically ill patients. As these conditions are also related to HLH, it is important to apply HLH-2004 criteria for exclusion of HLH in hyperferritinemic patients. Hyperferritinemic critically ill patients without HLH require quick investigation of differential diagnoses. MDPI 2022-12-27 /pmc/articles/PMC9821140/ /pubmed/36614993 http://dx.doi.org/10.3390/jcm12010192 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Schuster, Friederike S.
Nyvlt, Peter
Heeren, Patrick
Spies, Claudia
Adam, Moritz F.
Schenk, Thomas
Brunkhorst, Frank M.
Janka, Gritta
La Rosée, Paul
Lachmann, Cornelia
Lachmann, Gunnar
Differential Diagnosis of Hyperferritinemia in Critically Ill Patients
title Differential Diagnosis of Hyperferritinemia in Critically Ill Patients
title_full Differential Diagnosis of Hyperferritinemia in Critically Ill Patients
title_fullStr Differential Diagnosis of Hyperferritinemia in Critically Ill Patients
title_full_unstemmed Differential Diagnosis of Hyperferritinemia in Critically Ill Patients
title_short Differential Diagnosis of Hyperferritinemia in Critically Ill Patients
title_sort differential diagnosis of hyperferritinemia in critically ill patients
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821140/
https://www.ncbi.nlm.nih.gov/pubmed/36614993
http://dx.doi.org/10.3390/jcm12010192
work_keys_str_mv AT schusterfriederikes differentialdiagnosisofhyperferritinemiaincriticallyillpatients
AT nyvltpeter differentialdiagnosisofhyperferritinemiaincriticallyillpatients
AT heerenpatrick differentialdiagnosisofhyperferritinemiaincriticallyillpatients
AT spiesclaudia differentialdiagnosisofhyperferritinemiaincriticallyillpatients
AT adammoritzf differentialdiagnosisofhyperferritinemiaincriticallyillpatients
AT schenkthomas differentialdiagnosisofhyperferritinemiaincriticallyillpatients
AT brunkhorstfrankm differentialdiagnosisofhyperferritinemiaincriticallyillpatients
AT jankagritta differentialdiagnosisofhyperferritinemiaincriticallyillpatients
AT laroseepaul differentialdiagnosisofhyperferritinemiaincriticallyillpatients
AT lachmanncornelia differentialdiagnosisofhyperferritinemiaincriticallyillpatients
AT lachmanngunnar differentialdiagnosisofhyperferritinemiaincriticallyillpatients